Pharmaceutical Packaging Machinery Market - Growth, Trends, COVID-19 Impact, Forecasts (2021-2026)

The Global Pharmaceutical Packaging Machinery Market is expected to register a CAGR of approximately 7.5% during the forecast period (2021-2026). The spread of COVID-19 negatively impacted the market due to disruptions in the supply chain due to extended factory closures and delayed production globally. Logistically, it has been difficult for bottles, blister packaging, prefillable syringes, vials, and ampoules manufacturers to provide to pharma companies on time.

Key Highlights

• However, the global demand for pharmaceutical packaging is expected to increase for the next two to three years for the COVID-19 vaccine supply. Various vendors have been expanding their capacity to meet the surge in demand. This is expected to increase the demand for packaging machinery for the pharmaceutical industry globally.
• Pharmaceutical packaging is packaging products made using compatible materials for the transfer and storage of drugs. Based on the nature of the drug, packaging products are chosen from a range of material types and product types, provide protection, identification, and ensure the enclosed drug product's integrity.
• The pharmaceutical industry across the world has evolved considerably, owing to various factors that include the growth in regulatory norms worldwide and focus on population health management and invention. In addition, the growth in the demand for over-the-counter medicines and a more informed customer base is also driving the growth of the market.
• The pharmaceutical packaging market has a direct correlation with the pharmaceutical market. Any changes in demand for pharmaceutical drugs will impact the packaging market positively, as higher demand for new drugs leads to a greater need for packaging, thereby impacting the growth of the studied market.

Key Market Trends

The Presence of Safety Standards & Regulations in the Pharmaceutical Industry Expected to Drive the Market

• The pharmaceutical industry is highly regulated and is emphasizing the safety and sustainability aspects of manufacturing and packaging processes. Traceability legislations across the healthcare sector have been established to counter counterfeit drugs and medical devices.
• For instance, the US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs have set the minimum requirements for the methods, facilities, and controls used in the manufacturing, processing, and packaging of a drug.
• Similarly, the EU regulations mandate all pharmaceutical manufacturers to comply with the EU Good Manufacturing Practices (GMP), if they want to supply products to the EU. The manufacturers and importers must be authorized and registered by a competent authority from a member state. The manufacturers and importers are regularly inspected by an EU competent authority or other approved authority to check the compliance with the EU GMP. Hence, the presence of such regulations further necessitates the need for well-maintained and advanced packaging machinery to avoid product recalls.

North America Hold a Significant Market Share

• The North American region is expected to dominate the market in terms of demand for advanced packaging machinery for the pharma industry, owing to the significant growth of the pharmaceutical industry in the region, thereby driving the manufacturing of drugs in the region. Also, the United States is the largest market for drugs worldwide and accounts for about half of the R&D expenditure in the pharmaceutical and biotechnology markets.
• It is observed that the development of COVID-19 vaccines has led the allied companies to set up agreements with packaging companies for manufacturing syringes and vials. Such packaging trends acts as a major driver of growth in the packaging equipment market.
• Also, expanding capacities for vaccines has led the allied packaging engineering companies and OEMs witness an increasing demand for aseptic filling lines. in a response to such trends, pharaceutical packaging machinery players are launching fully integrated systems, plug-and-play solutions with modular concepts.
• Furthermore, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical market, both in consumption and development. According to STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019.
• The need to have proper infrastructure for the safe handling and safe containment of highly potent drugs, as well as the need for suitable analytical capabilities, particularly for high potency drugs, proper project management (that includes proper induction, running, and completion) highlight the need for R&D. Such trends are expected to boost the demand for packaging machinery in the region, with the growing manufacturing of drugs in the region.

Competitive Landscape

The competitive landscape of the global pharmaceutical packaging machinery market is moderately fragmented with the emergence of various machinery providers across the globe. The machinery providers are involved in strategic investments and partnerships for growth.

• February 2021 - ProMach acquired Serpa Packaging Solutions, a manufacturer of cartoning and end of line packaging systems for the pharmaceutical, medical device, nutraceutical, food, cosmetics, and personal care markets. The addition of Serpa brings automated cartoning systems into ProMach’s portfolio and expands its specialized secondary packaging machinery and line integration capabilities.
• October 2020 - Sharp, a provider of contract packaging and clinical supply services announced an investment of USD 10 million in equipment capabilities to directly support client demand in the biologics and injectables market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support